Popular Articles

A Selection Of Recent Studies And Surveys
The Urban Institute: "Capping The Tax Exclusion Of Employer-Sponsored Health Insurance: Is Equity Feasible?"
pharmacy online
Osteotech Completes Enrollment For DuraTech(TM) BioRegeneration Matrix Clinical Trial
Osteotech, Inc. (Nasdaq: OSTE), a leader in the emerging field of biologic products for regenerative healing, announced that it has completed enrollment for the clinical trial of its DuraTech(TM) BioRegeneration Matrix. Based upon Osteotech"s proprietary HCT(TM) (human collagen technology) platform, DuraTech is used to repair dura mater (the tough, outermost membrane surrounding the brain and spinal cord) during cranial surgical procedures.
News of the day
Foresight Biotherapeutics Announces Positive Results From An Open Label Pilot Study In Patients With Viral Conjunctivitis
Foresight Biotherapeutics, Inc. announced completion of a multi-center open-label pilot study of FST100 in the treatment of viral conjunctivitis. FST-100 is a novel formulation of dexamethasone that includes povidone iodine. The trial studied patients with clinical signs and symptoms of acute conjunctivitis who tested positive for adenoviral antigen by the RPS Adeno Detector® (RPS). Patients were enrolled in a single arm utilizing FST-100 topical ophthalmic suspension given 4 times daily for 5 days. The RPS Adeno Detector® test was performed at baseline and at each visit along with conjunctival swabs for adenoviral titers by quantitative PCR (qPCR) and cell culture with confirmatory immunoflourescence (CC-IFA). The primary endpoint of the study was clinical resolution of conjunctival injection and conjunctival discharge. These signs were scored on a scale from zero to three. Secondary endpoints included reduction of viral titers measured by qPCR and eradication of infectious virus determined by CC-IFA.
Mental Health

NPA Offers Private PGD Opportunity To Members - Seasonal Flu Vaccination

The NPA has launched an exciting new service enabling members to offer seasonal flu vaccinations to customers under a private Patient Group Direction (PGD) that the NPA is facilitating for its members, in line with our objective to provide additional business opportunities. Currently regulators require registration with the Health Care Commission and the involvement of a medical agency before a private PGD service can be set up. Members can now set up new services under private PGD without having to undertake this bureaucratic burden themselves. For this flu vaccination service the NPA is working with an established flu vaccination provider, The Health Station. A single fee of ÷£370 plus VAT (÷£425.50) provides all the training and support necessary for a 2009/10 seasonal flu vaccination service. The fee covers: - A comprehensive 1 day training course, specially prepared for pharmacists, practising the delivery of vaccinations, the management of anaphylaxis and resuscitation, and the use of PGDs - An Operations Manual - PGDs, supporting material, instructions on how to set up and deliver the service. - Window posters and patient leaflets for your pharmacy promoting the service. - A Clinical Governance programme supporting you and your customers. - A pharmacist support telephone help line available 7 days a week, from 8am until 10pm. Medical colleagues will answer any questions that you may have about any customer or clinical issues - A patient telephone helpline for any customer who needs support, available 24/7 following their vaccination. Importantly, there is no commitment to purchase a particular brand of flu vaccine; members can any brand and volume of vaccines that suits them. Raj Nutan, NPA Head of Business Development, comments: "Members were telling us that the burden of regulation was frustrating them if they wished to supply prescription medicines via private patient group directions. So we have embarked on developing a series of PGD opportunities that will provide them with a means of clearing the regulatory hurdle effortlessly. A bonus for NPA members is that they won"t need additional insurance - NPA Insurance already covers the pharmacist for providing flu vaccinations." "The NHS offers free seasonal flu vaccinations for all individuals in the at-risk groups, including people over the age of 65. That amounts to about 15 million vaccinations a year. Of those, only about 70% take them up . there are still over 6 million people who miss their free vaccination. Together with the 28 million in the working population below the age of 65, the market is very broad."


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):